LYMPHOCYTES for Myelodysplastic syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where LYMPHOCYTES was used for Myelodysplastic syndrome.
Most Reported Side Effects for LYMPHOCYTES
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 12 | 24.5% | 0 | 3 |
| Disease progression | 7 | 14.3% | 1 | 2 |
| Pneumonia | 7 | 14.3% | 3 | 1 |
| Acute graft versus host disease | 6 | 12.2% | 0 | 0 |
| Hypertension | 6 | 12.2% | 0 | 1 |
| Sepsis | 6 | 12.2% | 1 | 1 |
| Bacterial infection | 5 | 10.2% | 0 | 0 |
| Chronic graft versus host disease | 5 | 10.2% | 0 | 0 |
| Dry eye | 5 | 10.2% | 0 | 0 |
| Dysphagia | 5 | 10.2% | 0 | 0 |
| Extremity contracture | 5 | 10.2% | 0 | 0 |
| Eye irritation | 5 | 10.2% | 0 | 0 |
| Pain | 5 | 10.2% | 0 | 0 |
| Quality of life decreased | 5 | 10.2% | 0 | 0 |
Other Indications for LYMPHOCYTES
Other Drugs Used for Myelodysplastic syndrome
LENALIDOMIDE (14,132)
AZACITIDINE (5,741)
VENETOCLAX (2,508)
DEFERASIROX (1,445)
DARBEPOETIN ALFA (1,164)
RUXOLITINIB (886)
REVLIMID (835)
CEDAZURIDINE\DECITABINE (770)
LUSPATERCEPT-AAMT (609)
DECITABINE (429)